AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04901871 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 0.17 mg/kg, age<65
Description: Remimazolam of 0.17 mg/kg will be infused in patients aged\<65.
Study NCT04901871 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 0.22 mg/kg, age<65
Description: Remimazolam of 0.22 mg/kg will be infused in patients aged\<65.
Study NCT04901871 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 0.27 mg/kg, age<65
Description: Remimazolam of 0.27 mg/kg will be infused in patients aged\<65.
Study NCT04901871 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 0.02 mg/kg, age≥65
Description: Remimazolam of 0.02 mg/kg will be infused in patients aged≥65.
Study NCT04901871 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 0.07 mg/kg, age≥65
Description: Remimazolam of 0.07 mg/kg will be infused in patients aged≥65.
Study NCT04901871 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 0.12 mg/kg, age≥65
Description: Remimazolam of 0.12 mg/kg will be infused in patients aged≥65
Study NCT05174988 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Angle stitch
Description: Surgeon will use 0 polyglactin 910 suture on a tapered needle to place figure of 8 sutures on both (left and right) vaginal cuff apexes.
Study NCT04901871 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 0.17 mg/kg, age≥65
Description: Remimazolam of 0.17 mg/kg will be infused in patients aged≥65.
Study NCT06108063 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Losartan
Description: 12.5 mg oral Losartan taken for 28 days total (4 week postoperative).
Study NCT06108063 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo - Losartan
Description: Losartan appearance-matched Prosolv EasyTab SP placebo. 12.5 mg oral tablet taken for 28 days total (4 week postoperative).
Study NCT06531356 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: autologous amniotic fluid
Description: 10 cc of amniotic fluid aspirated after opening uterine incision in cesarean section, then Injected in edges of skin before closure
Study NCT06531356 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: No amniotic fluid injected in skin edges
Description: conventional closure of skin
Study NCT05972447 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Immediate implant placement of Ultrawide diameter dental implants
Description: immediate placement of ultrawide diameter dental implants in a fresh extraction socket of mandibular molar teeth
Study NCT04901871 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 0.22 mg/kg, age≥65
Description: Remimazolam of 0.22 mg/kg will be infused in patients aged≥65.
Study NCT04712526 — intervention group
Intervention type: DEVICE
Intervention: AEON Endostapler
Description: Surgery with AEON Endostapler
Study NCT04933682 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ALXN2050
Description: Oral tablet.
Study NCT04933682 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluconazole
Description: Oral tablet.
Study NCT04933682 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rifampin
Description: Oral capsule.
Study NCT06535984 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: White Noise
Description: White Noise Group (n=30) The third researcher turned on white noise (rain sound; link: https://www.youtube.com/watch?v=rZeM-HZeneo) before the start of the eye examination and played it to the infants until the end of the examination.
Study NCT06535984 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Swaddling
Description: Swaddling group (n=30) The third researcher swaddled each infant with its thin blanket. The swaddling involved bringing the infant's left hand close to the left buttock and wrapping it with the upper right end of the blanket. Similarly, she wrapped the baby's right hand with the upper left end of the blanket by bringing it closer to the right hip. She wrapped the baby's legs with the lower part of the blanket, ensuring that the baby's head could move freely.
Study NCT06535984 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: White Noise+Swaddling
Description: White Noise + Swaddling Group (n=30) The third researcher swaddled the infants in this group as described in the swaddling group and turned on the white noise (rain sound; link: https://www.youtube.com/watch?v=rZeM-HZeneo) before the examination started and played it to the infants until the examination was over.
Study NCT06536114 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CRISP: Criteria-Based Approach for the Rehabilitation for Non-Operative Shoulder Injuries
Description: The CRISP group will undergo physical therapy treatment, directed by a research physical therapist, including both supervised physical therapy and a guided home exercise program. This approach has three phases: stabilization, to facilitate joint protection; strength and endurance, to optimize functional capacity; and power, to prepare the Service member for returning to previous level of duty.
Study NCT06536114 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care
Description: The Standard of Care group will serve as the control arm and complete a period of physical rehabilitation under the supervision of a Military Health System physical therapist without study-specific guidance or interventions.
Study NCT04901871 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 0.27 mg/kg, age≥65
Description: Remimazolam of 0.27 mg/kg will be infused in patients aged≥65.
Study NCT06365151 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Osteopathic manual therapy
Description: osteopathic manual treatment aimed at improving the function and pain of the temporomandibular joint.
Study NCT06365151 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham osteopathic manual therapy
Description: a sham osteopathic manual treatment without therapeutic effect
Study NCT06386484 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PolarCap System
Description: The PolarCap Coolant flows through a silicone-based head cap. An insulating neoprene cover is put on top of the cap to isolate the cold. Using PolarCap system to selective head and neck cooling for 45 minutes post fight in boxing.
Study NCT05675345 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: HFNC only
Description: HFNC for 45 minutes, with FiO2 titrated to SpO2 of 90-97%
Study NCT05675345 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: HFNC + CNEP10
Description: HFNC with CNEP of 10 cmH2O for 45 minutes, with FiO2 titrated to SpO2 of 90-97%
Study NCT05171699 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: electroacupuncture
Description: The patients in Group EA received electroacupuncture at Zusanli (ST36) (located 5 mm below the head of the inferior fibula and 2 mm lateral to the anterior tibial tuberosity) and Baihui (DU20) (located in the midpoint of the parietal bone) acupoints, the stainless steel acupuncture needles were connected to a Hans acupoint nerve stimulator and inserted into the acupoints.
Study NCT05171699 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: shame electroacupuncture
Description: The patients in Group SEA received electroacupuncture at a shallow depth and 1 mm lateral to Zusanli (ST36) (located 5 mm below the head of the inferior fibula and 2 mm lateral to the anterior tibial tuberosity) and Baihui (DU20) (located in the midpoint of the parietal bone) acupoints, the stainless steel acupuncture needles were connected to a Hans acupoint nerve stimulator and inserted into the acupoints.
Study NCT05675345 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: HFNC + CNEP20
Description: HFNC with CNEP of 20 cmH2O for 45 minutes, with FiO2 titrated to SpO2 of 90-97%
Study NCT05675345 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: HFNC + CNEP30
Description: HFNC with CNEP of 30 cmH2O for 45 minutes, with FiO2 titrated to SpO2 of 90-97%
Study NCT06245785 — intervention group
Intervention type: PROCEDURE
Intervention: transarterial chemoembolisation
Description: Before TACE, hepatic arteriography was performed to evaluate the vascular anatomy and tumour vascularity. During TACE, a vascular catheter was selectively inserted into the tumour-feeding artery with an injection containing a mixture of doxorubicin (10-50 mg) and lipiodol (2-20 mL), followed by embolisation using gelatin sponge particles. TACE was repeated when residual viable tumours were confirmed or new lesions developed in patients with adequate liver function. Laboratory assessments were performed every four to six weeks. Radiological evaluation using contrast-enhanced computed tomography (CT) or magnetic resonance imaging (MRI) was recommended during weeks 4 and 8 after treatment and every 8 weeks thereafter. However, in clinical practice, the intensity of follow-up depends on an individual's baseline characteristics and response to the last treatment.
Study NCT05512494 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Quadrivalent Influenza Vaccine (Split Virion), inactivated
Description: The Quadrivalent Influenza Vaccine manufactured by Sinovac Biotech Co.,Ltd. The four influenza strains（including 4 antigens H1N1, H3N2, BV and BY, 15μg for each) in 0.5 mL of sodium chloride,disodium hydrogen phosphate,sodium dihydrogen phosphate water for per injection.The routine of administration is intramuscular injection into deltoid region.And the immunization schedule is one dose of quadrivalent influenza vaccine on day 0.
Study NCT05540236 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: auricular acupressure
Description: The experimental group were given therapeutic intervention of single ear auricular pellet acupressure at the stomach(CO4), cardia(CO3), liver(CO12), occiput(AT3), shenmen(TF4) and subcortex(AT4) acupuncture points
Study NCT05540236 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: sham auricular acupressure
Description: The control group were given sham intervention of single ear auricular pellet acupressure at the knee(AH4) and thoracic vertebrae(AH11) acupuncture points
Study NCT05127343 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Sealing deep pits and fissures
Description: Application of the pit and fissure sealant
Study NCT06114420 — intervention group
Intervention type: PROCEDURE
Intervention: salvage surgery
Description: Some patients who cannot undergo surgery
Study NCT04890002 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Far-infrared emitting pyjamas
Description: Clothing made in far infrared (FIR) - based textiles could be a sustainable way for alleviating sleep problems with many advantages. Firstly, the proposed far infrared textiles are made of man-made profiled fibers without the addition of chemicals such as ceramic additives or other related coatings.
Study NCT04890002 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham-pyjamas
Description: The sham-pyjamas are made of pure cotton fibres and man-made fibres without the far-infrared emitting function.
Study NCT04729803 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Experimental: Attention Guidance + Exposure
Description: 1. Participants will receive a brief standardized psychoeducation module, presented via a video recording.~2. Participants will then complete up to 10 analogue teleconferencing calls, each lasting a maximum of two minutes.~3. Between speeches participants will have a 1-minute break.~4. Participants will complete the subjective units of distress scale (SUDS) before and after each speech trial.~The experimental attention guidance condition: (1) the intervention rationale will include information about the importance of visually attending to the faces of the audience; (2) participants will be given target audience members to focus their gaze on during the their impromptu response. They will be told that they should look at and focus on the target audience member for the whole response.
Study NCT04729803 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Active Comparator: Exposure Alone
Description: 1. Participants will receive a brief standardized psychoeducation module, presented via a video recording.~2. Participants will then complete up to 10 analogue teleconferencing calls, each lasting a maximum of two minutes.~3. Between speeches participants will have a 1-minute break.~4. Participants will complete the subjective units of distress scale (SUDS) before and after each speech trial.
Study NCT04729803 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Experimental: Attention Control + Exposure
Description: 1. Participants will receive a brief standardized psychoeducation module, presented via a video recording.~   F~2. Participants will then complete up to 10 analogue teleconferencing calls, each lasting a maximum of two minutes. During each call participants will be prompted by one of the audience members.~3. Between speeches participants will have a 1-minute break.~4. Participants will complete the subjective units of distress scale (SUDS) before and after each speech trial.~The experimental attention control condition: (1) the intervention rationale will include information about the importance of attention control; (2) participants will be given target at the center of the screen to focus their gaze on during the their impromptu response. They will be told that they should look at and focus on the target for the whole response.
Study NCT06534281 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: BAO-G
Description: Using G-iliac system to reconstruct the visceral branches of in endovascular repair of thoracoabdominal aortic aneurysm.
Study NCT04826744 — intervention group
Intervention type: OTHER
Intervention: Standard dermatology consultation
Description: with clinical examination, score filling such as SCORAD and DLQI~* Standard Allergy consultation, with clinical examination, research of atopic or allergic personal and familial history~* Allergy skin testing: patch tests with the Standard European Battery and with some products bring by the patient if necessary, skin prick tests with aero allergens. Two reading of the patch tests will be performed, at H48 and H72.~* ophthalmologic consultation with slit lamp examination and OSDI (self questionnaire)
Study NCT04893993 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Thiamine
Description: Tablets. 300mg/tablet. Dosage depends on gender and weight
Study NCT04893993 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Placebo
Description: Tablets. Same number of tablets as Thiamine
Study NCT06194786 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Group D
Description: Usual care
Study NCT06138522 — intervention group
Intervention type: BEHAVIORAL
Intervention: Semi-structured interviews
Description: Semi-structured interviews
Study NCT06138522 — intervention group
Intervention type: BEHAVIORAL
Intervention: Child Post-Traumatic Stress Response Index (CPTS-RI) scale
Description: Child Post-Traumatic Stress Response Index (CPTS-RI) scale
Study NCT06138522 — intervention group
Intervention type: BEHAVIORAL
Intervention: - Therapeutic Alliance Questionnaire (HAQ-CP)
Description: - Therapeutic Alliance Questionnaire (HAQ-CP)
Study NCT06529666 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Didatic Session 1: Core Foundation Course
Description: A 45-minute foundational presentation covering key Weight Management Counseling (WMC) concepts, obesity bias, and cultural humility facilitated by a trained clinician-educator at the residency program delivered at baseline.
Study NCT06529666 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: The 3Ps Program
Description: 6 email modules delivered over months 2-8). Each 3P module will allow the resident to:~(1) Prepare: Review relevant concepts and demonstration videos sent via an email to prepare for completing the VCA vignettes; (2) Practice: Respond to brief vignettes of various 5As WMC challenging scenarios by audio recording their spoken response on the VCA tool; and (3) Process: Reflect on actionable expert and crowdsourced analogue patient feedback on the quality of their responses to each VCA vignette.
Study NCT06529666 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Didactic session 2
Description: (months 8-10): This 45-minute session will discuss key barriers to WMC adoption in clinical practice using real-world cases captured from residents facilitated by a trained clinician-educator at the residency program.
Study NCT06529666 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Email reinforcement
Description: 2 emails in months 10-12 covering key concepts in the preceding components.
Study NCT05356351 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RC48- ADC
Description: RC48-ADC 2.0 mg/kg D1,Triplizumab 3mg/kg D2，Q2W
Study NCT06529666 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: PowerPoint of the foundational course
Description: Residents will receive a core foundation slides on weight management counselling
Study NCT06529666 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PowerPoint of the foundational course
Description: Residents will receive a core foundation slides on weight management counselling
Study NCT05440578 — intervention group
Intervention type: DRUG
Intervention: olaparib plus bevacizumab maintenance therapy
Description: First-line olaparib plus bevacizumab maintenance therapy initiated from Aug 2018 up to Dec 2020 (the time range could be extended in order to recruit enough eligible subjects as required).
Study NCT05275777 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ADG106
Description: Administered as an intravenous infusion over 60-90 minutes in the initial cycle and over 30 minutes in subsequent cycle if well tolerated.
Study NCT05275777 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Doxorubicin
Description: Administered as an intravenous infusion.
Study NCT05275777 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Administered as an intravenous infusion.
Study NCT05275777 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: Administered as an intravenous infusion.
Study NCT06403566 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: hand massage
Description: three group randomized controlled trials
Study NCT06403566 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: hand massage
Description: three group randomized controlled trials
Study NCT05575947 — intervention group
Intervention type: DEVICE
Intervention: da Vinci Surgical System
Description: da Vinci Surgical System
Study NCT05575947 — intervention group
Intervention type: PROCEDURE
Intervention: laparoscopic bariatric surgery
Description: laparoscopic bariatric surgery
Study NCT05839860 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Salt 3 g
Description: Placebo group taking a breakfast meal and 3g salt on tomatoes before fasting for 7 hours
Study NCT05839860 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Salt 6 g
Description: Intervention group taking a breakfast meal and 6g salt on tomatoes plus 1 L water before fasting for 7 hours
Study NCT05839860 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Salt 9 g
Description: Intervention group taking a breakfast meal and 9g salt on tomatoes plus 1 L water before fasting for 7 hours
Study NCT04860726 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Joint mobilization
Description: Maitland Mobilization GIII and GIV i. PA Central and unilateral vertebral pressure ii.Transverse vertebral pressure iii. heating pad for 15 minutes
Study NCT05183997 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: PLACEBO_COMPARATOR
Intervention: complete blood count
Description: laboratory test
Study NCT04860726 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Myofascial Release
Description: Myofascial release is a hands-on soft tissue technique that facilitates a stretch into the restricted fascia. A sustained pressure is applied into the restricted tissue barrier; after 90-120 seconds the tissue will undergo histological length changes allowing the first release to be felt. The therapist will follow the release into a new tissue barrier and holds. After a few releases the tissue will become softer and more pliable.~The middle point of the Lateral raphae of the Thoracolumbarfascia between the posterior musculofascial junction of the Transversus Abdominis will be identified by ultrasonography. Vertical manual pressure will be applied on the middle point of the thoracolumbarfascia for 1 min ii. heating pad for 15 minutes
Study NCT04860726 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Joint mobilization & Myofascial Release
Description: Maitland Mobilization GIII and GIV i. PA Central and unilateral vertebral pressure ii.Transverse vertebral pressure iii. heating pad for 15 minutes iv. Myofascial release is a hands-on soft tissue technique that facilitates a stretch into the restricted fascia. A sustained pressure is applied into the restricted tissue barrier; after 90-120 seconds the tissue will undergo histological length changes allowing the first release to be felt. The therapist will follow the release into a new tissue barrier and holds. After a few releases the tissue will become softer and more pliable.~The middle point of the Lateral raphae of the Thoracolumbarfascia between the posterior musculofascial junction of the Transversus Abdominis will be identified by ultrasonography. Vertical manual pressure will be applied on the middle point of the thoracolumbarfascia for 1 min